Home
Company
Team
Investment Approach
For Entrepreneurs
Portfolio Companies
News & Events
Contact Us
Archive
2026
2025
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
News & Events
Filter
Year
Any
2026
2025
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
Keywords
> Submit
Page
18
19
20
21
22
Nuon - AFFYMAX CEO ARLENE MORRIS JOINS NUON THERAPEUTICSâ?? BOARD OF DIRECTORS AS CHAIRPERSON
09 / 07 / 2009
> Read More
ChemGenex to Seek Voluntary De-listing from NASDAQ and to Restructure Board to
29 / 06 / 2009
> Read More
ChemGenexâ??s Omacetaxine Kills Leukemic Stem Cells in Human CML Models
09 / 06 / 2009
> Read More
ChemGenexâ??s Omacetaxine Shows Activity in Refractory CML
09 / 06 / 2009
> Read More
Pivotal Study Results: ChemGenexâ??s Omacetaxine May Provide the First Viable Drug
02 / 06 / 2009
> Read More
ChemGenex Rights Issue Fully Subscribed, Further A$1 Million Placement Completed
27 / 05 / 2009
> Read More
ChemGenexâ??s Omacetaxine to be Showcased in Three Oral Presentations at EHA
21 / 05 / 2009
> Read More
Peplin - Weed sap lifts sun spots
19 / 05 / 2009
> Read More
Peplin `positive' on trial of sun spot treatment
19 / 05 / 2009
> Read More
Data boost for Peplin
19 / 05 / 2009
> Read More
ChemGenex to Present Pivotal Data in T315I Positive CML Patients as Oral
15 / 05 / 2009
> Read More
Sunshine Heart - Capital Raising and CFO Retirement
14 / 05 / 2009
> Read More
ChemGenex - ABN AMRO note on CXS May 2009
06 / 05 / 2009
> Read More
Xenome - Addition to US patent portfolio for Xen2174
23 / 04 / 2009
> Read More
Sunshine Heart Company - Medical Device Daily
22 / 04 / 2009
> Read More
Hatchtech board and management changes
21 / 04 / 2009
> Read More
Sunshine Heart - First U.S. C-Pulse Implants
20 / 04 / 2009
> Read More
Sunshine Heart - The Pulse First Implants
01 / 04 / 2009
> Read More
New Data Suggesting that ChemGenex's Omacetaxine Can Eradicate Leukemic
27 / 03 / 2009
> Read More
Xenome - Addition to US patent portfolio for Xen2174
23 / 03 / 2009
> Read More
Arana - Shareholder Update - Bid from Cephalon
10 / 03 / 2009
> Read More
Cephalon announces intention to offer $1.40 per share for Arana
27 / 02 / 2009
> Read More
STRATEGIC RELATIONSHIP UPDATE
18 / 02 / 2009
> Read More
Xenome Grants MedImmune License to xdiscoverT Venom Peptide Library
08 / 01 / 2009
> Read More
Positive Results for Peplin's Phase IIb AK Trial
08 / 01 / 2009
> Read More
Displaying records
476-500
of 705
